# Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

> **NCT03129347** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 14 (actual)

## Conditions studied

- Opioid-Related Disorders

## Interventions

- **DRUG:** Nalmefene

## Key facts

- **NCT ID:** NCT03129347
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2017-06-09
- **Final completion:** 2017-07-03
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03129347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03129347, "Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03129347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*